Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jan Bornschein

Showing results (81-90 of 93) with videos related to

Pageof 10
Sort By:
Helicobacter|April 15, 2026
Overview of Gastric Cancer Prevention Initiatives in EuropeMarcis Leja, Danute Ražuka-Ebela, Bojan Tepes, et al.
Therapeutic Advances in Gastrointestinal Endoscopy|December 1, 2025
Regular arrangement of collecting venules as a predictor of <i>Helicobacter pylori</i> absence using white-light endoscopy: a multicenter prospective study outside AsiaRodrigo Garcés-Duran, Joan Llach, Pedro Delgado-Guillena, et al.
Gut|March 11, 2025
British Society of Gastroenterology practice guidance on the management of acute and chronic gastrointestinal symptoms and complications as a result of treatment for cancerJervoise Andreyev, Richard Adams, Jan Bornschein, et al.
Endoscopy|September 3, 2025
Adherence to Clinical Practice Guidelines for Management of Epithelial Precancerous Conditions and Lesions in the Stomach in EuropeFilipa Fontes, Noa E A Kapteijn, Cesare Hassan, et al.
Digestive Diseases (Basel, Switzerland)|October 1, 2020
Biopsy Sampling in Upper Gastrointestinal Endoscopy: A Survey from 10 Tertiary Referral Centres Across EuropeJan Bornschein, Terry Tran-Nguyen, Gloria Fernandez-Esparrach, et al.
Nature Genetics|September 6, 2016
Mutational signatures in esophageal adenocarcinoma define etiologically distinct subgroups with therapeutic relevanceMaria Secrier, Xiaodun Li, Nadeera de Silva, et al.
Nature Genetics|February 1, 2017
Corrigendum: Mutational signatures in esophageal adenocarcinoma define etiologically distinct subgroups with therapeutic relevanceMaria Secrier, Xiaodun Li, Nadeera de Silva, et al.
Endoscopy|March 20, 2025
Management of epithelial precancerous conditions and early neoplasia of the stomach (MAPS III): European Society of Gastrointestinal Endoscopy (ESGE), European Helicobacter and Microbiota Study Group (EHMSG) and European Society of Pathology (ESP) Guideline update 2025Mário Dinis-Ribeiro, Diogo Libânio, Hugo Uchima, et al.
Gut|March 11, 2019
Immune activation by DNA damage predicts response to chemotherapy and survival in oesophageal adenocarcinomaRichard C Turkington, Laura A Knight, Jaine K Blayney, et al.
Gut|July 11, 2025
<i>Helicobacter pylori</i> antibiotic resistance: a global challenge in search of solutionsChristian Schulz, Jyh-Ming Liou, Mohamed Alboraie, et al.
Pageof 10

Showing results (81-90 of 93) with videos related to

Sort By:
Pageof 10
Helicobacter|April 15, 2026
Overview of Gastric Cancer Prevention Initiatives in EuropeMarcis Leja, Danute Ražuka-Ebela, Bojan Tepes, et al.
Therapeutic Advances in Gastrointestinal Endoscopy|December 1, 2025
Regular arrangement of collecting venules as a predictor of <i>Helicobacter pylori</i> absence using white-light endoscopy: a multicenter prospective study outside AsiaRodrigo Garcés-Duran, Joan Llach, Pedro Delgado-Guillena, et al.
Gut|March 11, 2025
British Society of Gastroenterology practice guidance on the management of acute and chronic gastrointestinal symptoms and complications as a result of treatment for cancerJervoise Andreyev, Richard Adams, Jan Bornschein, et al.
Endoscopy|September 3, 2025
Adherence to Clinical Practice Guidelines for Management of Epithelial Precancerous Conditions and Lesions in the Stomach in EuropeFilipa Fontes, Noa E A Kapteijn, Cesare Hassan, et al.
Digestive Diseases (Basel, Switzerland)|October 1, 2020
Biopsy Sampling in Upper Gastrointestinal Endoscopy: A Survey from 10 Tertiary Referral Centres Across EuropeJan Bornschein, Terry Tran-Nguyen, Gloria Fernandez-Esparrach, et al.
Nature Genetics|September 6, 2016
Mutational signatures in esophageal adenocarcinoma define etiologically distinct subgroups with therapeutic relevanceMaria Secrier, Xiaodun Li, Nadeera de Silva, et al.
Nature Genetics|February 1, 2017
Corrigendum: Mutational signatures in esophageal adenocarcinoma define etiologically distinct subgroups with therapeutic relevanceMaria Secrier, Xiaodun Li, Nadeera de Silva, et al.
Endoscopy|March 20, 2025
Management of epithelial precancerous conditions and early neoplasia of the stomach (MAPS III): European Society of Gastrointestinal Endoscopy (ESGE), European Helicobacter and Microbiota Study Group (EHMSG) and European Society of Pathology (ESP) Guideline update 2025Mário Dinis-Ribeiro, Diogo Libânio, Hugo Uchima, et al.
Gut|March 11, 2019
Immune activation by DNA damage predicts response to chemotherapy and survival in oesophageal adenocarcinomaRichard C Turkington, Laura A Knight, Jaine K Blayney, et al.
Gut|July 11, 2025
<i>Helicobacter pylori</i> antibiotic resistance: a global challenge in search of solutionsChristian Schulz, Jyh-Ming Liou, Mohamed Alboraie, et al.
Pageof 10